Carlumab - CAS 915404-94-3

Carlumab is a high-affinity human monoclonal antibody that targets CCL2, blocking its interaction with the CCR2 receptor, thereby inhibiting CCL2-mediated tumour growth and suppressing the recruitment of monocytes/macrophages in the tumour microenvironment. It can be used for prostate and breast cancer research.

CCR

GPCR/G Protein, Microbiology/Virology, Immunology/Inflammation

915307

0.973

-20°C

Ice Packs

Inhibitory Antibodies